Online citations, reference lists, and bibliographies.

Immunophenotypic Diagnosis Of Leukemic B-Cell Chronic Lymphoproliferative Disorders Other Than Chronic Lymphocytic Leukemia

A. Orfao, J. Almeida, M. Sánchez, J. S. Miguel
Published 2004 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Leukemic B-cell chronic lymphoproliferative disorders (B-CLPD) are a relatively heterogeneous group of diseases, all of which exhibit a clonal expansion of mature-appearing B-lymphoid cells in the peripheral blood (PB). Both primary leukemias and the leukemic phase of primary lymphomas are included in this category (1). Among the primary B-cell leukemias, chronic lymphocytic leukemia (CLL), prolymphocytic leukemia (PLL), and hairy cell leukemia (HCL) are usually considered; within the primary lymphomas, follicular lymphoma (FL), mantle cell lymphoma (MCL), marginal zone splenic lymphoma (MZSL), lymphoplasmacytic lymphoma (LPL), and the large B-cell lymphomas (LCLs) exhibit PB involvement more frequently (1).
This paper references
10.1007/978-3-642-60377-8_53
Immunophenotypic Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia
J. Ciudad (1997)
10.1182/BLOOD.V90.8.2863
Recent Advances in Flow Cytometry: Application to the Diagnosis of Hematologic Malignancy
J. Cd (1997)
10.1002/(sici)1097-0320(19971015)30:5<245::aid-cyto5>3.0.co;2-g
U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: data reporting.
R. Braylan (1997)
10.1016/B978-012448510-5/50117-5
Commentary on and reprint of Bouroncle BA, Wiseman BK, Doan CA, Leukemic reticuloendotheliosis, in Blood (1958) 13:609–630
M. Lichtman (2000)
10.1006/GENO.2000.6479
Expression and replication timing patterns of wildtype and translocated BCL2 genes.
Y. Sun (2001)
Atypical lymphocytic
V Deneys
10.1023/A:1008330311886
Follicular large cell lymphoma: long-term follow-up of 62 patients treated between 1973-1981.
J. Rodriguez (2000)
Quantitative criteria for clonality in the diagnosis of B-cell non-Hodgkin's lymphoma by flow cytometry.
W. A. Geary (1993)
10.1200/JCO.2000.18.2.317
European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma.
J. Foran (2000)
Hairy cell leukemia. What is new forty years after the first description? Hematol Cell Ther 1998;40:139–148
X Troussard (1998)
Contribution ofimmunophenotype inthe diagnosis andclassification ofhaemopoietic malignancies
E. Matutes (1995)
10.1046/j.1365-2141.1996.t01-1-4061079.x
Detection of monoclonality in bone marrow plasma cells by flow cytometry: limitations for minimal residual disease detection
M. Ocqueteau (1996)
10.1016/S0022-1759(01)00338-6
Reference values for peripheral blood B-lymphocyte subpopulations: a basis for multiparametric immunophenotyping of abnormal lymphocytes.
V. Deneys (2001)
10.1111/j.1600-0609.2001.00313.x
Flow cytometry using the monoclonal antibody CD10‐Pe/Cy5 is a useful tool to identify follicular lymphoma cells
M. Bellido (2001)
10.1038/sj.leu.2402584
Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation
M. Sánchez (2002)
10.1038/sj.leu.2402346
Atypical lymphocytic leukemia and mantle cell lymphoma immunologically very close: flow cytometric distinction by the use of CD20 and CD54 expression
V. Deneys (2002)
Leukemia-associated changes identified by quantitative flow cytometry. III. B-cell gating in CD37 k/l clonality test. Leukemia 1994;8:1864–1870
R Peters (1994)
10.1023/A:1008375931236
World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.
N. Harris (1999)
10.1309/123P-CE6V-WYAK-BB1F
Flow cytometric analysis of cerebrospinal fluid samples and its usefulness in routine clinical practice.
D. Subirá (2002)
10.1084/JEM.188.9.1691
Identification of Functional Human Splenic Memory B Cells by Expression of CD148 and CD27
S. Tangye (1998)
10.1002/1097-0320(20010215)46:1<23::AID-CYTO1033>3.0.CO;2-Z
Optimal number of reagents required to evaluate hematolymphoid neoplasias: results of an international consensus meeting.
R. Braylan (2001)
[Possibilities of differential diagnosis of B-cell chronic lymphoproliferative diseases using monoclonal antibodies].
Samoĭlova Rs (1990)
10.1200/JCO.1999.17.12.3835
The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997.
N. Harris (1999)
Incidence and clinico - biologic characteristics of biclonality in leukemic B - cell Chronic lymphoproliferative disorders ( B - CLPD )
ML Sanchez
10.1111/j.1365-2141.1986.tb07575.x
The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia
J. Melo (1986)
Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection.
J. Ciudad (1998)
10.1182/blood.V65.3.620.bloodjournal653620
Hairy cell leukemia: a tumor of pre-plasma cells.
K. Anderson (1985)
10.1111/j.1365-2141.1991.tb07975.x
Immunophenotypic heterogeneity of multiple myeloma: influence on the biology and clinical course of the disease
J. F. San Miguel (1991)
10.1084/JEM.188.9.1679
Human Immunoglobulin (Ig)M+IgD+ Peripheral Blood B Cells Expressing the CD27 Cell Surface Antigen Carry Somatically Mutated Variable Region Genes: CD27 as a General Marker for Somatically Mutated (Memory) B Cells
U. Klein (1998)
10.1038/sj.leu.2400828
The spectrum of chronic lymphoproliferative disorders in Hong Kong. A prospective study
Lc Chan (1997)
10.1111/j.1365-2141.1986.tb02202.x
The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia
J. Melo (1986)
CD10 expression in follicular lymphoma and large cell lymphoma is different from that of reactive lymph node follicles.
N. Almasri (1998)
10.1046/j.1365-2141.1996.d01-1711.x
Splenic lymphoma with villous lymphocytes: clinical presentation, biology and prognostic factors in a series of 100 patients
X. Troussard (1996)
10.1038/sj.leu.2400638
Cytogenetic analysis of CD34+ subpopulations in AML and MDS characterized by the expression of CD38 and CD117
D. Haase (1997)
10.1182/BLOOD.V89.4.1288
Evidence for a large compartment of IgM-expressing memory B cells in humans.
U. Klein (1997)
A patient with a variant form of hairy cell leukaemia.
P. A. Kramer (1993)
Clinical utility of flow cytometry in the chronic lymphoid leukemias.
Joseph A. DiGiuseppe (1998)
10.1182/BLOOD.V92.9.3203.421K34_3203_3209
Four-color flow cytometric investigation of terminal deoxynucleotidyl transferase-positive lymphoid precursors in pediatric bone marrow: CD79a expression precedes CD19 in early B-cell ontogeny.
M. Dworzak (1998)
The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia
JV Melo (1986)
The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.
E. Matutes (1994)
10.3109/10428199709058599
Hairy cell leukemia and allied chronic lymphoid leukemias: current knowledge and new therapeutic options.
A. Polliack (1997)
10.1182/blood.v38.3.288.288
Leukemic reticuloendotheliosis.
B. Bouroncle (1958)
10.1046/j.1365-2141.2001.03019.x
Loss of CD20 expression following treatment with rituximab (chimaeric monoclonal anti‐CD20): a retrospective cohort analysis
J. Foran (2001)
10.1182/blood.V84.5.1361.bloodjournal8451361
A Revised European-American Classification of Lymphoid Neoplasms : A Proposal From the International Lymphoma Study Group
N. L. Harris (1994)
10.1385/0-89603-485-2:427
Flow cytometry.
V. Daniel (1998)
Residual disease in B-cell chronic lymphocytic leukemia patients and prognostic value.
B. Lenormand (1994)
10.1016/S0037-1963(01)90045-9
Flow cytometric analysis of lymphomas and lymphoproliferative disorders.
M. Stetler-Stevenson (2001)
10.1111/j.1365-2141.1986.tb05563.x
The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia
J. Melo (1986)
Hairy cell leukemia. What is new forty years after the first description?
X. Troussard (1998)
10.1097/00125480-199811000-00011
Mantle cell lymphoma.
Paul J. Kurtin (1998)
10.1007/978-3-642-60162-0_18
Phenotypic and Molecular Characterization of Human Peripheral Blood B-cell Subsets with Special Reference to N-Region Addition and Jκ-Usage in VκJκ-Joints and κ/λ-Ratios ixn Naive Versus Memory B-cell Subsets to Identify Traces of Receptor Editing Processes
U. Klein (1999)
and mantle cell lymphoma immunologically very close : flow cytometric distinction by use of CD 20 and CD 54 expression
E Moreau (2001)
10.1038/sj.leu.2401840
Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1
C. Wuchter (2000)
10.1182/blood.v90.6.2465
Immunophenotyping investigation of minimal residual disease is a useful approach for predicting relapse in acute myeloid leukemia patients.
J. S. San Miguel (1997)
10.1002/(SICI)1097-0320(19971015)30:5<249::AID-CYTO6>3.0.CO;2-C
U.S.-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: medical indications.
B. H. Davis (1997)
10.1038/sj.leu.2400835
Analysis of residual disease in chronic lymphocytic leukemia by flow cytometry
E. Cabezudo (1997)
from normal B precursors with four color flow cytometry : implications for minimal residual disease detection
K Agematsu (1999)
10.1002/1097-0142(197411)34:5<1813::aid-cncr2820340532>3.0.co;2-6
Leukemic reticuloendotheliosis
F. Naeim (1974)
10.1093/ANNONC/11.SUPPL_1.S137
Molecular response assessed by PCR is the most important factor predicting failure-free survival in indolent follicular lymphoma: update of the MDACC series.
A. López-Guillermo (2000)
Advances in the lymphoproliferative disorders. Review of our experience in the study of over 1000 cases
E Matutes (1989)
10.1136/jcp.48.3.189
The leukaemic phase of non-Hodgkin's lymphoma.
B. Bain (1995)
10.1182/blood.V83.6.1558.bloodjournal8361558
The immunophenotype of splenic lymphoma with villous lymphocytes and its relevance to the differential diagnosis with other B-cell disorders.
E. Matutes (1994)
10.1097/00001622-199701000-00006
Chronic lymphoproliferative disorders.
E. Montserrat (1997)
10.1182/blood.v90.8.2863
Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy.
C. D. Jennings (1997)
Basic techniques for the detection of human T and B lymphocytes in tissues
TL Whiteside (1980)
Flow cytometric detection of intracellular antigens for immunophenotyping of normal and malignant leukocytes.
K. Groeneveld (1996)
10.1056/NEJM199510193331606
Chronic lymphocytic leukemia.
C. Rozman (1995)
Clinical utility od CD23 and FMC7 antigen coexistent expression in B-cell lymphoproliferative disorder subclassification. Cytometry 2002;50:1–7
E Ahmad (2002)
Detection of acute
C Wuchter
10.1038/sj.leu.2401219
Occult B cell malignancies can be detected by three-color flow cytometry in patients with cytopenias
D. Wells (1998)
10.1111/j.1600-065X.1998.tb01447.x
Somatic hypermutation in normal and transformed human B cells
Ulf Klien (1998)
The membrane phenotype of hairy cell leukemia: a study with monoclonal antibodies.
J. Melo (1984)
Immunophenotype of the chronic lymphoproliferative disorders
E. Matutes (1998)
B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules.
L. Trentin (1997)
Leukemia-associated changes identified by quantitative flow cytometry. III. B-cell gating in CD37/kappa/lambda clonality test.
R. Peters (1994)
10.1016/S0140-6736(97)10295-1
Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia
E. Coustan-Smith (1998)
10.1016/S0968-6053(00)80051-4
A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.
N. Harris (1994)
Flow cytometric analysis of cerebrospinal fluid samples and its utility in routine clinical practice
D Subira (2002)
DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas.
M. Czader (1995)
A CD10-positive subset of malignant cells is identified in multiple myeloma using PCR with patient-specific immunoglobulin gene primers.
J M Cao (1995)
10.1046/j.1365-2141.1997.2273044.x
The significance of minimal residual disease in hairy cell leukaemia treated with deoxycoformycin: a long‐term follow‐up study
E. Matutes (1997)
10.1111/j.1600-0609.1999.tb01767.x
Different expression of adhesion molecules on CD34+ cells in AML and B‐lineage ALL and their normal bone marrow counterparts
M. Waele (1999)
10.3109/10428199409056295
Hairy Cell Leukemia: a Clinical Review Based on 725 Cases of the Italian Cooperative Group (ICGHCL)
A. Frassoldati (1994)
10.1385/IR:21:1:23
CD27/CD70 interactions regulate T dependent B cell differentiation
S. Jacquot (2000)
10.1136/jcp.42.6.567
Proposals for the classification of chronic (mature) B and T lymphoid leukaemias. French-American-British (FAB) Cooperative Group.
J. Bennett (1989)
10.1016/S0002-9440(10)65443-0
Composite low grade B-cell lymphomas with two immunophenotypically distinct cell populations are true biclonal lymphomas. A molecular analysis using laser capture microdissection.
F. Fend (1999)
10.1182/BLOOD.V87.11.4483.BLOODJOURNAL87114483
Mantle cell lymphoma-- an entity comes of age.
D. Weisenburger (1996)
Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B ALL. Leukemia 1999;13:419–427
P Lucio (1999)
10.3109/10428190009057637
Expression of the CD11c Antigen in B-Cell Chronic Lymphoproliferative Disorders
G. Marotta (2000)
10.1016/S0145-2126(00)00114-4
Cyclin D1 by flow cytometry as a useful tool in the diagnosis of B-cell malignancies.
M. Elnenaei (2001)
10.1046/J.1468-0734.2000.00002.X
Morphological and immunophenotypic features of chronic lymphocytic leukemia.
E. Matutes (2000)
10.1038/sj.leu.2401511
CD79b expression in B cell chronic lymphocytic leukemia: its implication for minimal residual disease detection
J. G. Vela (1999)
Clínica, biología y formas variantes de tricoleucemia
BA Bouroncle (1992)
- associated changes identified by quantitative flow cytometry . III . B - cell gating in CD 37 k / l clonality test
R Peters (1994)
10.1038/sj.leu.2402200
Atypical lymphocytic leukemia and mantle cell lymphoma immunologically very close: flow cytometric distinction by the use of CD20 and CD54 expression
V. Deneys (2001)
10.1016/s0197-1859(82)80068-x
Leukemic reticuloendotheliosis (hairy cell leukemia).
B. Bouroncle (1979)
10.1038/sj.leu.2401364
A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: implications for residual disease detection
EG Weir (1999)
10.1200/JCO.1999.17.6.1869
Expression of beta-integrin adhesion molecules in non-Hodgkin's lymphoma: correlation with clinical and evolutive features.
M. Terol (1999)
Consensus protocol for the flow cytometric immunophenotyping of hematopoietic malignancies. Working Group on Flow Cytometry and Image Analysis.
G. Rothe (1996)
Splenic lymphoma with circulating villous lymphocytes/splenic marginal-zone lymphoma.
D. Catovsky (1999)
10.1182/BLOOD.V98.1.29
Quantitation of minimal disease levels in chronic lymphocytic leukemia using a sensitive flow cytometric assay improves the prediction of outcome and can be used to optimize therapy.
A. Rawstron (2001)
10.1309/VJTK-DJWA-X297-XF8Q
Follicular lymphoma can be distinguished from benign follicular hyperplasia by flow cytometry using simultaneous staining of cytoplasmic bcl-2 and cell surface CD20.
D. Cornfield (2000)
10.1002/CYTO.10045
Clinical utility of CD23 and FMC7 antigen coexistent expression in B-cell lymphoproliferative disorder subclassification.
E. Ahmad (2002)
Therapy of B-cell lymphoma with anti-CD20 antibodies can result in the loss of CD20 antigen expression.
T. Davis (1999)
10.1182/BLOOD.V88.11.4110.BLOODJOURNAL88114110
The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene.
S. Iida (1996)
10.1093/CLINCHEM/45.10.1708
Clinically useful information provided by the flow cytometric immunophenotyping of hematological malignancies: current status and future directions.
A. Orfao (1999)
10.1016/0090-1229(88)90180-8
Clinical and immunological findings in large B-cell chronic lymphocytic leukemia.
A. Orfao (1988)
10.1093/CLINCHEM/44.5.944
Serum protein electrophoresis and immunofixation by a semiautomated electrophoresis system.
X. Bossuyt (1998)
Phenotypic and molecular characterization of human peripheral blood B-cell subsets with special reference to N-region addition and J kappa-usage in V kappa J kappa-joints and kappa/lambda-ratios in naive versus memory B-cell subsets to identify traces of receptor editing processes.
U. Klein (1999)
: medical indications
TL Whiteside (1997)
10.1038/sj.leu.2401279
Flow cytometric analysis of normal B cell differentiation: a frame of reference for the detection of minimal residual disease in precursor-B-ALL
P. Lucio (1999)
10.1093/AJCP/108.4.378
Improvement of the chronic lymphocytic leukemia scoring system with the monoclonal antibody SN8 (CD79b).
E J Moreau (1997)
10.1038/sj.leu.2401517
Quantification of cellular adhesion molecules on malignant B cells from non-Hodgkin’s lymphoma
Mc Jacob (1999)
10.14670/HH-15.573
Memory B cells and CD27.
K. Agematsu (2000)
The immunophenotype of hairy cell leukemia (HCL). Proposal for a scoring system to distinguish HCL from B-cell disorders with hairy or villous lymphocytes.
E. Matutes (1994)
Randomized clinical trials in adult acute lymphoblastic leukemia: which is the question?
R. Bassan (1998)
10.1182/BLOOD.V88.10.3919.BLOODJOURNAL88103919
Prognostic implications of ploidy and proliferative activity in the diffuse, aggressive non-Hodgkin's lymphomas.
J. Winter (1996)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar